What does Pdc Line Pharma do?
PDC line Pharma specializes in developing innovative therapeutic solutions for cancer treatment. The company focuses on harnessing the power of its proprietary technologies to create more effective and targeted therapies. With a commitment to advancing healthcare, PDC line Pharma aims to improve patient outcomes through its research and development efforts.
Juridical situation
Company number
Founding date
EUID number
Type of enterprise
Location
Juridical form
- Signals
-
Juridical warningJuridical warning
The legal status points to elevated risk (e.g. dissolution or bankruptcy).
Negative equityNegative equity € -7.80MEquity is negative: debts exceed assets (technically insolvent).
Reporting lossesReporting losses € -16.57MThe company reported a loss in the latest financial year.
Negative cashflowNegative cashflow € -1.16MOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -6.72MEBITDA is negative: operating activities are loss-making.
Healthy social debtHealthy social debt 9.5%Social debts stay manageable relative to personnel costs.
- Directors
- Carkath Srl, Jpp Consulting Srl, Societe Federale De Participations Et D'investissement Sa, +6 more
- Shareholders
- Societe Federale De Participations Et D'investissement 19,34%, Orsa Tech 2,75%, Belean.net 0,28%
|
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|
|
€
2.90M
|
€
-483K
|
€
-599K
|
€
82K
|
|
|
€
-6.72M
|
€
-2.59M
|
€
-1.84M
|
€
-1.79M
|
|
|
€
-11.01M
|
€
-5.79M
|
€
-5.98M
|
€
-5.30M
|
|
|
€
-7.80M
|
€
3.21M
|
€
9.00M
|
€
20.81M
|
|
|
-207.5%
|
25.71%
|
49.74%
|
76.66%
|
|
|
€
6.09M
|
€
9.27M
|
€
9.06M
|
€
5.95M
|
|
|
€
2.78M
|
€
3.47M
|
€
11.11M
|
€
10.91M
|
|
|
20.60
|
21.30
|
17.80
|
13.80
|
Publications 23
All publications- Demissions, Nominations 21/06/2024
- Statuts (Traduction, Coordination, Autres Modifications, ) 15/04/2024
- Divers 11/01/2024
- Demissions, Nominations 14/12/2023
- Statuts (Traduction, Coordination, Autres Modifications, ) - Capital, Actions 04/07/2023
Frequently asked questions
Answers to the most common questions about Pdc Line Pharma, based on official government data and the filed annual accounts.
What is the VAT number of Pdc Line Pharma?
The VAT number of Pdc Line Pharma is BE0657.842.221.
How many employees work at Pdc Line Pharma?
In 2024, Pdc Line Pharma employed 20.60 full-time equivalents (FTE).
When was Pdc Line Pharma established?
Pdc Line Pharma was founded in 30-06-2016.
What is the official address of Pdc Line Pharma?
The official address of Pdc Line Pharma is Boulevard De Patience Et Beaujonc 3/6 Liège 4000.
What is the legal form of Pdc Line Pharma?
The juridical form of Pdc Line Pharma is Public limited company (NV/SA).
What is the legal situation of Pdc Line Pharma?
The legal situation of Pdc Line Pharma is Vrijwillige ontbinding – vereffening.
What is the annual revenue of Pdc Line Pharma?
The annual revenue of Pdc Line Pharma is €0.
What does Pdc Line Pharma do?
PDC line Pharma specializes in developing innovative therapeutic solutions for cancer treatment. The company focuses on harnessing the power of its proprietary technologies to create more effective and targeted therapies. With a commitment to advancing healthcare, PDC line Pharma aims to improve patient outcomes through its research and development efforts.
Where can I find Pdc Line Pharma?
Pdc Line Pharma is located at Boulevard De Patience Et Beaujonc 3/6 Liège 4000 in Liège (4000).
Is Pdc Line Pharma a reliable company?
Pdc Line Pharma is a registered Rechtspersoon with company number 0657.842.221 and can be verified through the official CBE database.
What is the credit limit of Pdc Line Pharma?
The estimated credit limit of Pdc Line Pharma is €0.
Is Pdc Line Pharma still active?
Pdc Line Pharma currently has the status "Vrijwillige ontbinding – vereffening" and is inactief.